Enanta Pharmaceuticals (ENTA) Selling, General & Administrative (2012 - 2026)
Enanta Pharmaceuticals (ENTA) recorded Selling, General & Administrative of $9.47 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 5.3% from $10 million a year earlier and down 1.0% from the prior quarter.
Enanta Pharmaceuticals (ENTA) Selling, General & Administrative (2012 - 2026) Analysis & Trends
On a TTM basis, Enanta Pharmaceuticals' Selling, General & Administrative came in at $37.75 million as of Jun 30, 2026, down 21.2% year-over-year; for FY2025 (ended Sep 30, 2025), it was $43.93 million, down 24.1% from FY2024.
- Annual Selling, General & Administrative has a five-year compound annual growth rate of 9.9% (FY2020 to FY2025).
- Across earlier fiscal years, Selling, General & Administrative came in at $57.85 million in FY2024 (+9.4%), $52.89 million in FY2023 (+16.3%), $45.48 million in FY2022 (+39.8%) and $32.54 million in FY2021 (+18.9%).
- Quarterly Selling, General & Administrative has ranged from $8.36 million in fiscal Q4 2021 to $16.52 million in fiscal Q1 2024 over the past five years.
- On a year-over-year basis, Selling, General & Administrative has declined for eight consecutive quarters, with an average decline of 18.6% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 52.5% in fiscal Q3 2022, against a decline of 29.9% in fiscal Q1 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $9.57 million (Q2 2026), $9.01 million (Q1 2026) and $9.7 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Enanta Pharmaceuticals | 377.40 Mn | -350.60 Mn | - | 9.47 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.47 Mn |
| Mar 31, 2026 | 9.57 Mn |
| Dec 31, 2025 | 9.01 Mn |
| Sep 30, 2025 | 9.70 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 11.39 Mn |
| Dec 31, 2024 | 12.85 Mn |
| Sep 30, 2024 | 13.68 Mn |
| Jun 30, 2024 | 13.41 Mn |
| Mar 31, 2024 | 14.24 Mn |
| Dec 31, 2023 | 16.52 Mn |
| Sep 30, 2023 | 13.80 Mn |
| Jun 30, 2023 | 12.62 Mn |
| Mar 31, 2023 | 13.78 Mn |
| Dec 31, 2022 | 12.70 Mn |
| Sep 30, 2022 | 12.57 Mn |
| Jun 30, 2022 | 12.93 Mn |
| Mar 31, 2022 | 10.48 Mn |
| Dec 31, 2021 | 9.51 Mn |
| Sep 30, 2021 | 8.36 Mn |
Enanta Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();